{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:10:37Z","timestamp":1771629037536,"version":"3.50.1"},"reference-count":83,"publisher":"Japanese Society of Tropical Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trop.Med.Health"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2149\/tmh.2010-18","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T06:11:40Z","timestamp":1294985500000},"page":"17-30","source":"Crossref","is-referenced-by-count":19,"title":["The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji"],"prefix":"10.2149","volume":"39","author":[{"given":"Eisaku","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"911","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dreyer G, Piessens WF. In: Nutman TB (editor). <I>Lymphatic Filariasis.<\/I> London: Imperial College Press; 2000: 245-264.","DOI":"10.1142\/9781848160866_0010"},{"key":"2","unstructured":"2. Otsuji Y. In: Kimura E, Rim H-J, Sun D, Weerasooriya MV (editors). <I>Asian Parasitology Vol. III Filariasis in Asia and Western Pacific Islands.<\/I> Chiba: AAA Committee&frasl;Federation of Asian Parasitologists; 2005: 81-92."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. <I>Parasitology<\/I> 1996; 112: 409-428.","DOI":"10.1017\/S0031182000066646"},{"key":"4","unstructured":"4. WHO. World Health Report 1998 - Life in the 21st century: A vision for all."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Perera M, Whitehead M, Molyneux D, Weerasooriya M, Gunatilleka G. Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis. <I>PLoS Negl Trop Dis<\/I> 2007; 1: 2 (e128).","DOI":"10.1371\/journal.pntd.0000128"},{"key":"6","unstructured":"6. WHO. World Health Report 2000 - Health systems: improving performance."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ramaiah KD, Das PK, Michael E, Guyatt H. The economic burden of lymphatic filariasis in India. <I>Parasitol Today<\/I> 2000; 16: 251-253.","DOI":"10.1016\/S0169-4758(00)01643-4"},{"key":"8","unstructured":"8. WHO. Weekly Epidemiological Record 2008; 83: 333-347."},{"key":"9","unstructured":"9. Hewitt RI, Kushner S, Stewart HW, White E, Wallace WS, SubbaRow Y. Experimental chemotherapy of filariasis. III. Effect of 1-diethylcarbamyl-4-methylpiperazine hydrochloride against naturally acquired filarial infections in cotton rats and dogs. <I>J Lab Clin Med<\/I> 1947; 32: 1314-1329."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Santiago-Stevenson D, Oliver-Gonzalez J, Hewitt RI. The treatment of filariasis bancrofti with 1-diethylcarbamyl-4-methylpiperazine hydrochloride (Hetrazan). <I>Ann N Y Acad Sci <\/I>1948; 50: 161-170.","DOI":"10.1111\/j.1749-6632.1948.tb39850.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Trent SC. Reevaluation of World War II veterans with filariasis acquired in the South Pacific. <I>Am J Trop Med Hyg<\/I> 1963; 12: 877-887.","DOI":"10.4269\/ajtmh.1963.12.877"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Otto GF, Jachowski Jr LA, Wharton JD. Filariasis in American Samoa III. Studies on chemotherapy against the nonperiodic form of <I>Wuchereria bancrofti. Am J Trop Med Hyg<\/I> 1953; 2: 495-516.","DOI":"10.4269\/ajtmh.1953.2.495"},{"key":"13","unstructured":"13. Mahoney LE, Kessel JF. Treatment failure in filariasis mass treatment programmes. <I>Bull World Health Organ<\/I> 1971; 45: 35-42."},{"key":"14","unstructured":"14. Manson-Bahr P. The action of hetrazan in Pacific filariasis. <I>J Trop Med Hyg<\/I> 1952; 55: 169-173."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Burnett GF, Mataika JU. Mass-administration of diethylcarbamazine citrate in preventing transmission of aperiodic human filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1961; 55: 178-187.","DOI":"10.1016\/0035-9203(61)90023-2"},{"key":"16","unstructured":"16. Kessel JF. An effective programme for the control of filariasis in Tahiti. <I>Bull World Health Organ<\/I> 1957; 16: 633-664."},{"key":"17","unstructured":"17. Sasa M. <I>Human filariasis - a global survey of epidemiology and control.<\/I> Tokyo: University of Tokyo Press; 1976: 500-501."},{"key":"18","unstructured":"18. WHO. WHO Expert Committee on Filariasis (<I>Wuchereria<\/I> and <I>Brugia<\/I> Infections): Second Report 1967."},{"key":"19","unstructured":"19. WHO. WHO Expert Committee on Filariasis: Third Report 1974."},{"key":"20","unstructured":"20. WHO. Lymphatic Filariasis: Fourth report of the WHO Expert Committee on Filariasis 1984."},{"key":"21","unstructured":"21. Hawking F. A review of progress in the chemotherapy and control of filariasis since 1955. <I>Bull World Health Organ<\/I> 1962; 27: 555-568."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. McGregor IA, Gilles HM. Further studies on the control of bancroftian filariasis in West Africa by means of diethylcarbamazine. <I>Ann Trop Med Parasitol<\/I> 1960; 54: 415-418.","DOI":"10.1080\/00034983.1960.11686004"},{"key":"23","unstructured":"23. Laigret J, Fagneaux G, Tuira E. Progr&egrave;s dans l&rsquo;emploi de la di&eacute;thylcarbamazine en chimioth&eacute;rapie de la filariose lymphatique &agrave; <I>Wuchereria bancrofti<\/I> var. <I>pacifica<\/I>: la m&eacute;thode des doses espac&eacute;es. <I>Bull World Health Organ<\/I> 1978; 56: 985-990."},{"key":"24","unstructured":"24. Laigret J, Fagneaux G, Tuira E. Chimioth&eacute;rapie de masse par la di&eacute;thylcarbamazine en doses espac&eacute;es: effets obtenus &agrave; Tahiti sur la microfilar&eacute;mie &agrave; <I>Wuchereria bancrofti,<\/I> var. <I>pacifica. Bull World Health Organ<\/I> 1980; 58: 779-783."},{"key":"25","unstructured":"25. Kimura E, Penaia L, Spears GFS. Epidemiology of subperiodic bancroftian filariasis in Samoa 8 years after control by mass treatment with diethylcarbamazine. <I>Bull World Health Organ<\/I> 1985; 63: 869-880."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Burnett GF and Mataika JU. Mass administration of diethylcarbamazine citrate in preventing transmission of aperiodic human filariasis II. Results of a blood survey made four years after drug administration. <I>Trans Roy Soc Trop Med Hyg<\/I> 1964; 58: 545-551.","DOI":"10.1016\/0035-9203(64)90111-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mataika JU, Dando BC, Spears GFS, MacNamara FN. Mosquito-borne infections in Fiji I. Filariasis in northern Fiji: epidemiological evidence regarding factors influencing the prevalence of microfilaraemia of <I>Wuchereria bancrofti<\/I> infections. <I>J Hyg Camb<\/I> 1971; 69: 273-286.","DOI":"10.1017\/S0022172400021501"},{"key":"28","unstructured":"28. Sasa M. <I>Human filariasis - a global survey of epidemiology and control.<\/I> Tokyo: University of Tokyo Press; 1976: 536-540."},{"key":"29","unstructured":"29. Mataika JU, Mataitoga MV, Kimura E. Recent situation of filariasis in Lau and Rotuma provinces in Fiji. <I>Fiji Med J<\/I> 1985; 13: 211-214."},{"key":"30","unstructured":"30. Mataika JU, Kimura E, Koroivueta J. Shimada M. Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. <I>Bull World Health Organ<\/I> 1998; 76: 575-579."},{"key":"31","unstructured":"31. Kimura E, Penaia L, Spears GFS. The efficacy of annual single-dose treatment with diethylcarbamazine citrate against diurnally subperiodic bancroftian filariasis in Samoa. <I>Bull World Health Organ<\/I> 1985; 63: 1097-1106."},{"key":"32","unstructured":"32. Kimura E, Spears GFS, Singh KI, Samarawickrema WA, Penaia L, Sone PF, Pelenatu S, Faaiuaso ST, Self LS, Dazo BC. Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic <I>Wuchereria bancrofti:<\/I> eight years&rsquo; experience in Samoa. <I>Bull World Health Organ<\/I> 1992; 70: 769-776."},{"key":"33","unstructured":"33. Sasa M. <I>Human filariasis - a global survey of epidemiology and control.<\/I> Tokyo: University of Tokyo Press; 1976: 700-705."},{"key":"34","unstructured":"34. Mataika J, Kimura E, Koroivueta J. Kaisuva JN, Brown M, Tuivaga J, Bikai S, Govind SR. Comparison of the efficacy of diethylcarbamazine between 5 rounds of annual single-dose treatment and an intensive 28-dose treatment spread over 2 years against diurnally subperiodic <I>Wuchereria bancrofti<\/I> in Fiji. <I>Fiji Med J<\/I> 1993; 19: 2-6."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kimura E & Mataika JU. Control of lymphatic filariasis by annual single-dose diethylcarbamazine treatments. <I>Parasitol Today<\/I> 1996; 12: 240-244.","DOI":"10.1016\/0169-4758(96)10014-4"},{"key":"36","unstructured":"36. Kimura E, Penaia L, Samarawickrema WA, Spears GFS. Low-density microfilaremia in subperiodic bancroftian filariasis in Samoa. <I>Bull World Health Organ<\/I> 1985; 63: 1089-1096."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Samarawickrema WA, Spears GFS, Sone F, Ichimori K, Cummings RF. Filariasis transmission in Samoa I. Relation between density of microfilariae and larval density in laboratory-bred and wild-caught <I>Aedes (Stegomyia) polynesiensis<\/I> (Marks) and wild-caught <I>Aedes (Finlaya) samoanus<\/I> (Gruenberg). <I>Ann Trop Med Parasitol<\/I> 1985; 79: 89-100.","DOI":"10.1080\/00034983.1985.11811892"},{"key":"38","unstructured":"38. Pichon G, Merlin M, Fagneaux G, Rivi&eacute;re F, Laigret J. Etude de la distribution des num&eacute;rations microfilariennes dans les foyer de filariose lymphatique. <I>Tropenmed Parasitol<\/I> 1980; 31: 165-180."},{"key":"39","unstructured":"39. Cartel JL, Celerier P, Spiegel A, Burucoa C, Roux JF. A single diethylcarbamazine dose for treatment of <I>Wuchereria bancrofti<\/I> carriers in French Polynesia: efficacy and side effects. <I>Southeast Asian J Trop Med Public Health<\/I> 1990; 21: 465-470."},{"key":"40","unstructured":"40. Schuurkamp GJ, Kereu RK, Bulungol PK, Kawereng A, Spicer PE. Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: Phase 2 - annual single-dose treatment. <I>PNG Med J<\/I> 1994; 37: 65-81."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Andrade LD, Medeiros Z, Pires ML, Pimentel A, Rocha A, Figueredo-Silva J, Coutinho A, Dreyer G. Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1995; 89: 319-321.","DOI":"10.1016\/0035-9203(95)90561-8"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Meyrowitsch DW, Simonsen PE, Makunde WH. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments. <I>Trans Roy Soc Trop Med Hyg<\/I> 1996; 90: 69-73.","DOI":"10.1016\/S0035-9203(96)90484-8"},{"key":"43","unstructured":"43. Panicker KN, Krishnamoorthy K, Sabesan S, Prathiba J, Abidha. Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis. <I>Southeast Asian J Trop Med Public Health<\/I> 1991; 22: 402-411."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. <I>Am J Trop Med Hyg<\/I> 1993; 49: 804-811.","DOI":"10.4269\/ajtmh.1993.49.804"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Amaral F, Dreyer G, Figueredo-Silva J, Nor&otilde;es J, Cavalcanti A, Samico SC, Santos A, Coutinho A. Live adult worms detected by ultrasonography in human bancroftian filariasis. <I>Am J Trop Med Hyg<\/I> 1994; 50: 753-757.","DOI":"10.4269\/ajtmh.1994.50.753"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Mand S, Marfo-Debrekyei Y, Dittrich M, Fischer K, Adjei O, Hoerauf A. Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. <I>Filaria J <\/I>2003; 2: 3.","DOI":"10.1186\/1475-2883-2-3"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nor&otilde;es J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addiss D. Assessment of the efficacy of diethylcarbamazine on adult <I>Wuchereria bancrofti<\/I> in vivo. <I>Trans Roy Soc Trop Med Hyg<\/I> 1997; 91: 78-81.","DOI":"10.1016\/S0035-9203(97)90405-3"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Figueredo-Silva J, Jungmann P, Nor&otilde;es J, Piessens WF, Coutinho A, Brito C, Rocha A, Dreyer G. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1996; 90: 192-194.","DOI":"10.1016\/S0035-9203(96)90138-8"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.21.3150"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ottesen EA, Vijayasekaran V, Kumaraswami V, Perumal Pillai SV, Sadanandam A, Frederick S, Prabhakar R, Tripathy SP. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. <I>New Eng J Med<\/I> 1990; 322: 1113-1117.","DOI":"10.1056\/NEJM199004193221604"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Addiss DG, Eberhard ML, Lammie PJ, McNeeley MB, Lee SH, McNeeley DF, Spencer HC. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against <I>Wuchereria bancrofti<\/I> microfilaremia. <I>Am J Trop Med Hyg<\/I> 1993; 48: 178-185.","DOI":"10.4269\/ajtmh.1993.48.178"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Dreyer G, Coutinho A, Miranda D, Nor&otilde;es J, Rizzo JA, Galdino E, Rocha A, Medeiros Z, Andrade LD, Santos A, Figueredo-Silva J, Ottesen EA. Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine. <I>Trans Roy Soc Trop Med Hyg<\/I> 1995; 89: 98-102.","DOI":"10.1016\/0035-9203(95)90674-6"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Dreyer G, Nor&otilde;es J, Amaral F, Nen A, Medeiros Z, Coutinho A, Addiss D. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1995; 89: 441-443.","DOI":"10.1016\/0035-9203(95)90049-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Moulia-Pelat JP, Nguyen LN, Hasco&euml;t H, Luquiaud P, Nicolas L. Advantages of an annual single dose of ivermectin 400 micrograms&frasl;kg plus diethylcarbamazine for community treatment of bancroftian filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1995; 89: 682-685.","DOI":"10.1016\/0035-9203(95)90443-3"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Dreyer G, Addis D, Santos A, Figueredo-Silva J, Nor&otilde;es J. Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult <I>Wuchereria bancrofti. Trans Roy Soc Trop Med Hyg<\/I> 1998; 92: 219-222.","DOI":"10.1016\/S0035-9203(98)90754-4"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(99)01486-6"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KSA, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DCL, Michalski ML, Dissanaike AS. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 1998; 92: 94-97.","DOI":"10.1016\/S0035-9203(98)90972-5"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Ismail MM, Jayakody RL, Weil GJ, Fernand D, de Silva MSG, de Silva GAC, Balasooriya WK. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. <I>Trans Roy Soc Trop Med Hyg<\/I> 2001; 95: 332-335.","DOI":"10.1016\/S0035-9203(01)90257-3"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. El Setouhy M, Ramzy RMR, Ahmed ES, Kandil AM, Hussain O, Farid HA, Helmy H, Weil GJ. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for the treatment of bancroftian filariasis. <I>Am J Trop Med Hyg<\/I> 2004; 70: 191-196.","DOI":"10.4269\/ajtmh.2004.70.191"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.2.179"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2006.05.003"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Dunyo SK, Nkrumah FK, Simonsen PE. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. <I>Trans Roy Soc Trop Med Hyg<\/I> 2000; 94: 205-211.","DOI":"10.1016\/S0035-9203(00)90278-5"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Dunyo SK, Nkrumah FK, Simonsen PE. Single-dose treatment of <I>Wuchereria bancrofti<\/I> infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. <I>Trans Roy Soc Trop Med Hyg<\/I> 2000; 94: 437-443.","DOI":"10.1016\/S0035-9203(00)90135-4"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Pani SP, Reddy GS, Das LK, Vanamail P, Hoti SL, Ramesh J, Das PK. Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of <I>Wuchereria bancrofti<\/I> in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study. <I>Filaria J<\/I> 2002; 1: 1.","DOI":"10.1186\/1475-2883-1-1"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Rizzo JA, Belo C, Lins R, Dreyer G. Children and adolescents infected with <I>Wuchereria bancrofti<\/I> in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. <I>Ann Trop Med Parasitol<\/I> 2007; 101: 423-433.","DOI":"10.1179\/136485907X176517"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Dreyer G, Addiss D, Williamson J, Nor&otilde;es J. Efficacy of co-administered diethylcarbamazine and albendazole against adult <I>Wuchereria bancrofti. Trans Roy Soc Trop Med Hyg<\/I> 2006; 100: 1118-1125.","DOI":"10.1016\/j.trstmh.2006.04.006"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Addiss D, Gamble CL, Garner P, Gelband H, Ejere HOD, Critchley JA, International Filariasis Review Group. Albendazole for lymphatic filariasis. <I>Cochrane Database Syst Rev<\/I> 2005; (4): CD003753.","DOI":"10.1002\/14651858.CD003753.pub3"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Beau de Rochars M, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. <I>Am J Trop Med Hyg<\/I> 2004; 71: 466-470.","DOI":"10.4269\/ajtmh.2004.71.466"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Mani TR, Rajendran R, Sunish IP, Munirathinam A, Arunachalam N, Satyanarayana K, Dash AP. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. <I>Trop Med Int Health<\/I> 2004; 9: 1030-1035.","DOI":"10.1111\/j.1365-3156.2004.01298.x"},{"key":"70","unstructured":"70. Dreyer G, Addiss D, Dreyer P, Nor&otilde;es J. <I>Basic Lymphoedema Management: Treatment and prevention of problems associated with lymphatic filariasis.<\/I> Hollis: Hollis Publishing Company; 2002: 1-112."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Addiss DG, Brady MA. Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature. <I>Filaria J<\/I> 2007; 6: 2.","DOI":"10.1186\/1475-2883-6-2"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The global programme to eliminate lymphatic filariasis: Health impact after 8 years. <I>PLoS Negl Trop Dis<\/I> 2008; 2: 10 (e317).","DOI":"10.1371\/journal.pntd.0000317"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, Jha P, Musgrove P, Chow J, Shahid-Salles S, Jamison DT. Advancement of global health: key messages from the Disease Control Priorities Project. <I>Lancet<\/I> 2006; 367: 1193-1208.","DOI":"10.1016\/S0140-6736(06)68440-7"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, Fischer PU, Henderson RH, Kazura JW, Lammie PJ, Njenga SM, Ottesen EA, Ramaiah KD, Richards FO, Weil GJ, Williams SA. Determinants of success in national programs to eliminate lymphatic filariasis: A perspective identifying essential elements and research needs. <I>Am J Trop Med Hyg<\/I> 2008; 79: 480-484.","DOI":"10.4269\/ajtmh.2008.79.480"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Dash AP, Tyagi BK. Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. <I>Bull World Health Organ<\/I> 2007; 85: 138-145.","DOI":"10.2471\/BLT.06.029389"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Gambhir M, Michael E. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis. <I>PLoS ONE<\/I> 2008; 3: 8 (e2874).","DOI":"10.1371\/journal.pone.0002874"},{"key":"77","unstructured":"77. Yoshida C. In: Kimura E, Rim H-J, Sun D, Weerasooriya MV (editors). <I>Asian Parasitology Vol. III Filariasis in Asia and Western Pacific Islands.<\/I> Chiba: AAA Committee&frasl;Federation of Asian Parasitologists; 2005: 109-118."},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Weerasooriya MV, Yahathugoda CT, Wickremasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, Weerasekara SH, Samarawickrema WA. Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. <I>Filaria J<\/I> 2007; 6: 11.","DOI":"10.1186\/1475-2883-6-11"},{"key":"79","unstructured":"79. WHO&frasl;TDR. Community directed treatment with ivermectin: Report of a multi-country study (TDR&frasl;AFR&frasl;RP&frasl;96.1), 1996."},{"key":"80","unstructured":"80. WHO&frasl;TDR. Community-directed treatment of lymphatic filariasis in Africa: Report of a multi-centre study (TDR&frasl;IDE&frasl;RP&frasl;CDTI&frasl;00.2), 2000."},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. WHO&frasl;APOC. Revitalising health care delivery in sub-Saharan Africa: The potential of community-directed interventions to strengthen health systems, 2007.","DOI":"10.2471\/TDR.08.978-924-1596602"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Blackburn BG, Eigege A, Gotau H, Gerlong G, Miri E, Hawley WA, Mathieu E, Richards F. Successful integration of insecticide-treated bet net distribution with mass drug administration in Central Nigeria. <I>Am J Trop Med Hyg<\/I> 2006; 75: 650-655.","DOI":"10.4269\/ajtmh.2006.75.650"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. WHO&frasl;TDR. Community-directed interventions for major health problems in Africa: A multi-country study. Final Report, 2008.","DOI":"10.2471\/TDR.08.978-924-1596602"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T12:04:23Z","timestamp":1621512263000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tmh\/39\/1\/39_2010-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2149\/tmh.2010-18","relation":{},"ISSN":["1349-4147","1348-8945"],"issn-type":[{"value":"1349-4147","type":"electronic"},{"value":"1348-8945","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}